Literature DB >> 22822019

Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease.

Philippe Gagnon1, Jean S Bussières, Fernanda Ribeiro, Serge L Gagnon, Didier Saey, Nathalie Gagné, Steeve Provencher, François Maltais.   

Abstract

RATIONALE: Lower limb muscle dysfunction contributes to exercise intolerance in chronic obstructive pulmonary disease (COPD). We hypothesized that signaling from lower limb muscle group III/IV sensory afferents to the central motor command could be involved in premature cycling exercise termination in COPD.
OBJECTIVES: To evaluate the effects of spinal anesthesia, which presumably inhibited central feedback from the lower limb muscle group III/IV sensory afferents on exercise tolerance and cardiorespiratory response during constant work-rate cycling exercise in patients with COPD.
METHODS: In a crossover and double-blind randomized design, eight patients with COPD (FEV(1), 67 ± 8% predicted) completed a constant work-rate cycling exercise after sham (NaCl, interspinous L(3)-L(4)) or active (fentanyl 25 μg, intrathecal L(3)-L(4)) spinal anesthesia.
MEASUREMENTS AND MAIN RESULTS: When compared with placebo, endurance time was significantly prolonged after spinal anesthesia with fentanyl (639 ± 87 s vs. 423 ± 38 s [mean ± SEM]; P = 0.01). Ventilation and respiratory rate were reduced at isotime points under the fentanyl condition, whereas ventilatory efficiency and dead space ventilation were improved. Patients exhibited less dynamic hyperinflation at isotime points with spinal anesthesia. Consequently, the rise in dyspnea was significantly flatter during the fentanyl condition than with placebo.
CONCLUSIONS: Spinal anesthesia enhanced cycling exercise tolerance in patients with COPD, mostly by reducing ventilatory response and dyspnea during exercise; these effects were possibly mediated through the inhibition of group III/IV lower limb sensory muscle afferents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22822019     DOI: 10.1164/rccm.201203-0404OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

1.  Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.

Authors:  Keisuke Miki; Ryoji Maekura; Noritoshi Nagaya; Mari Miki; Seigo Kitada; Kenji Yoshimura; Masahide Mori; Kenji Kangawa
Journal:  J Physiol Sci       Date:  2015-02-28       Impact factor: 2.781

2.  Group III/IV muscle afferents limit the intramuscular metabolic perturbation during whole body exercise in humans.

Authors:  Gregory M Blain; Tyler S Mangum; Simranjit K Sidhu; Joshua C Weavil; Thomas J Hureau; Jacob E Jessop; Amber D Bledsoe; Russell S Richardson; Markus Amann
Journal:  J Physiol       Date:  2016-07-08       Impact factor: 5.182

3.  Muscle activation during exercise in severe acute hypoxia: role of absolute and relative intensity.

Authors:  Rafael Torres-Peralta; José Losa-Reyna; Miriam González-Izal; Ismael Perez-Suarez; Jaime Calle-Herrero; Mikel Izquierdo; José A L Calbet
Journal:  High Alt Med Biol       Date:  2014-12       Impact factor: 1.981

Review 4.  Pathophysiology of human ventilatory control.

Authors:  Jerome A Dempsey; Curtis A Smith
Journal:  Eur Respir J       Date:  2014-06-12       Impact factor: 16.671

Review 5.  The 'sensory tolerance limit': A hypothetical construct determining exercise performance?

Authors:  Thomas J Hureau; Lee M Romer; Markus Amann
Journal:  Eur J Sport Sci       Date:  2016-11-07       Impact factor: 4.050

6.  Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?

Authors:  Jerome A Dempsey; Andre La Gerche; James H Hull
Journal:  J Appl Physiol (1985)       Date:  2020-08-13

Review 7.  Submissive hypercapnia: Why COPD patients are more prone to CO2 retention than heart failure patients.

Authors:  Chi-Sang Poon; Chung Tin; Gang Song
Journal:  Respir Physiol Neurobiol       Date:  2015-04-17       Impact factor: 1.931

8.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

9.  Type III-IV muscle afferents are not required for steady-state exercise hyperpnea in healthy subjects and patients with COPD or heart failure.

Authors:  Chi-Sang Poon; Gang Song
Journal:  Respir Physiol Neurobiol       Date:  2015-04-21       Impact factor: 1.931

10.  Deception Improves Time Trial Performance in Well-trained Cyclists without Augmented Fatigue.

Authors:  Paul Ansdell; Kevin Thomas; Glyn Howatson; Markus Amann; Stuart Goodall
Journal:  Med Sci Sports Exerc       Date:  2018-04       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.